Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04734015
Other study ID # DK091250
Secondary ID 5R01DK091250-07I
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 18, 2021
Est. completion date June 1, 2026

Study information

Verified date April 2024
Source Johns Hopkins Bloomberg School of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Together Overcoming Diabetes (TOD) is a culturally tailored, family-based type 2 diabetes management and preventive intervention. Participants in this trial are American Indian adult caregivers diagnosed with type 2 diabetes and their youth, aged 10-16 years at enrollment. Adult/youth participant dyads will be enrolled across 5 Ojibwe tribal communities. Consenting participant dyads will be randomized into one of two groups: Group A: begin the intervention program immediately; Group B (waitlist): begin the intervention program in 2 years. Both groups will complete assessments with study staff at baseline, 3, 6, 12, 18, and 24 months to assess HbA1c, cholesterol, blood pressure (adults), biometric measures, and psychosocial and behavioral outcomes (adults and youth). The 14-lesson intervention program will be delivered in the participant's home by local Family Health Coaches over a 6-month period. Upon completion of the intervention, participants may also be invited to participate in a "Ripple Effects Mapping" (REM) session for discussions, and mapping of the intervention effects.


Description:

Together Overcoming Diabetes (TOD) is a culturally tailored, family-based type 2 diabetes management and preventive intervention. The program activates family and cultural practices that encourage healthy diets and physical activities, promotes coping skills for dealing with stress, and reconnects families via a home-based intervention taught by American Indian (AI) paraprofessional Family Health Coaches. Evaluation of TOD for this trial will happen via Community Based Participatory Research (CBPR). The study team will enroll "target" adult caregivers diagnosed with type 2 diabetes and their youth, ages 10-16 years at enrollment, with the goal of tapping motivational reciprocity between the two generations. The work involves collaboration with five Ojibwe tribal communities in the midwestern U.S. to implement a randomized controlled study with a wait-list design respectful of cultural norms of inclusion. The study will evaluate effectiveness of the intervention on adult physiological (primary outcome = HbA1c), behavioral, and mental health and children's psychosocial, familial, behavioral and physiological risk and protective factors for diabetes. The research will also identify stress-coping mechanisms that mediate the impact of the intervention on health. A novel collaborative, qualitative evaluation technique will map potential "ripple effects" of the intervention within families and communities. If effective, the intervention will promote dissemination and scaling with tribal health coaches, community involvement, and stakeholder (health providers, health and human service agencies) input.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 162
Est. completion date June 1, 2026
Est. primary completion date April 1, 2025
Accepts healthy volunteers No
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria: ADULT (target participants) - Are greater than 18 years of age - Self-identify as American Indian - Have a completed verification form from a healthcare provider indicating a confirmed diagnosis of type 2 diabetes - Live on or within 30 miles of participating reservations - Are a caregiver to a 10-16 year-old who lives in their home - Are willing to be randomly put into Group A (intervention) or Group B (waitlist control) - Are willing to complete all lessons and assessments - Speak and read English - Are not cognitively or visually impaired (able to review and sign informed consent and complete assessments) YOUTH - 10 -16 years of age - Self-identify as American Indian - Live with an adult who has joined the study - Are willing to be randomly put into Group A or Group B - Are willing to complete all lessons and assessments - Speak and read English - Are not cognitively or visually impaired (able to review and sign informed consent and complete assessments) Exclusion Criteria: ADULTS (target participants) - Are not American Indian - No confirmed type 2 diabetes diagnosis - Not a caregiver to a youth ages 10-16 in their home - Does not live within the distance inclusion criteria - Is unable to complete the study procedures - Has comorbidity(ies) that may have an impact on type 2 diabetes management YOUTH - Are not American Indian - Do not fall within the specified age range of 10-16 years at time of enrollment - Do not have an enrolled Adult caregiver - Unable to read and speak English - Not willing to complete the study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Together Overcoming Diabetes (TOD)
Curriculum approaches health through a holistic lens of spiritual, mental, physical and emotional wellness. American Indian Family Health Coaches conduct motivational interviewing to help participant dyads (adult caregivers with Type 2 diabetes and their youth) set attainable goals and work through obstacles to reach those goals.

Locations

Country Name City State
United States Johns Hopkins University Great Lakes Hub Duluth Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins Bloomberg School of Public Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in Physical Activity - Adult and Youth participants Survey questions will ask about physical activity duration, frequency, intensity. Higher score equates to better outcome. Day 0, Month 6, Month 12, and Month 24
Other Change in Communal Mastery - Adult and Youth participants Communal Mastery as a Coping Resource. Scoring ranges from 0 to 3. Higher score equates to better outcome. Day 0, Month 6, Month 12, and Month 24
Other Change in Diabetes Empowerment - Adult participants Diabetes Empowerment Scale (short form, Anderson, et al., 2003). Scoring ranges from 0 to 3. Higher score equates to better outcome. Day 0, Month 6, Month 12, and Month 24
Primary Change in Adult Participant Fasting HbA1c Change in hemoglobin A1c Day 0, Month 3, Month 6, Month 12, Month 18, and Month 24
Secondary Change in BMI/zBMI - Adult and Youth participants zBMI change as indication of weight loss Day 0, Month 3, Month 6, Month 12, Month 18, and Month 24
Secondary Change in Depression and Depressive symptoms - Adult and Youth participants Patient Health Questionnaire (PHQ-9) Adult and Adolescent versions. Scoring ranges from 0 to 3. Higher total score equates to worse outcome. Day 0, Month 3, Month 6, Month 12, Month 18, and Month 24
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A